Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Molecular Partners ADR MOLN

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.


NDAQ:MOLN - Post by User

Post by whytestockson Jun 20, 2024 10:15am
27 Views
Post# 36097736

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are
NEWS: $MOLN Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | BenzingaShares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with ...MOLN - Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga

<< Previous
Bullboard Posts
Next >>